Vendor Intelligence Report: OmegAmino

Executive summary

OmegAmino is a young, influencer-native peptide storefront with a visible operator and a narrow but clean Finnrick lab record. Across 4 Finnrick lab tests the overall pass rate is 100% (4 pass / 0 fail). The evidence supports Retatrutide specifically; it does not justify a catalog-wide quality assumption, and Finnrick’s methodology-divergence charts show the rating compresses under stricter scoring.

The ownership trail is unusually identifiable for this market: the site access flow, social profiles, and trademark records all point toward Chase Irons and Chase Irons Fitness, LLC. That visibility is a positive relative to anonymous peptide shops, but the report also documents a contract-name mismatch in archived terms, a February 2025 launch footprint, login-walled commerce, and coupon infrastructure consistent with an early-stage direct-to-consumer operation.

The sharper buyer risks sit around transaction integrity and product traceability. Public complaints describe post-order EPCS or insurance-style fee demands before fulfillment; the report treats attribution cautiously, but the pattern is serious because customer funds may already be exposed. A separate forum trail describes GLP products being removed for regulatory reasons and later restored under new names, while OmegAmino-like clone domains create additional confusion about which site, label, or COA belongs to the real vendor.

Bottom line: OmegAmino is a more defensible Retatrutide option than its short history would otherwise suggest, but only within the limits of the Finnrick-tested product. For renamed GLPs, SS-31, or any batch without verifiable lab documentation, the full report’s entity mapping, clone-domain analysis, fee-demand handling guidance, and product-identity notes matter before ordering.

Inside the full report:

• Appendix A Finnrick laboratory data, methodology-divergence charts, and rating trajectory for the Retatrutide record
• Corporate and trademark records tying OmegAmino to Chase Irons Fitness, LLC, plus the archived terms-name inconsistency
• Domain, hosting, staging-site, WooCommerce, HubSpot, and coupon-stack infrastructure analysis
• Clone-site analysis of omegaminoglp.shop and official-brand warning evidence
• Trustpilot and Reddit review chronology, including reported EPCS/insurance-fee demands
• Affiliate and discount-code scan covering X, Instagram, Reddit, and coupon sites

Risk assessment

• Reported EPCS / advance-fee payment demands — high: Multiple public customer reports describe $150-$350 extra fees before fulfillment; unverified but repeated pattern resembles advance-fee fraud and directly affects order funds.
• Regulatory and product-identity obfuscation risk — high: Forum records say GLP-1/2/3, Omegatide and Cagrilintide were removed by Dec 31, 2025, then restored under new names after SAFE Drugs Act failed; buyers may lose compound identity traceability.
• Brand-confusion and copycat-control risk — medium: omegaminoglp.shop and omegaminos.com were flagged by the official Instagram warning; the official site provides limited anti-counterfeit signals beyond warnings, leaving buyer verification burden high.
• COA and lab-transparency gap outside Finnrick-tested Retatrutide — medium: Finnrick record supports Retatrutide only (4 tests, 4 pass / 0 fail; 82.16%); archived vendor COA page lacked downloadable COAs or lab-portal verification for broader catalog.
• Undisclosed affiliate-promotion risk — medium: Affiliate scan found discount-code and bio-link promotion with no or unclear disclosure, including @bojaxgoat and Code Tommy, which can bias social recommendations.